OpenAI CEO Sam Altman is co-founding Merge Labs, a brain-computer interface startup positioned to compete directly with Elon Musk’s Neuralink. According to The Financial Times, the company plans to raise $250 million at an $850 million valuation, with a large portion of its funding expected from OpenAI’s ventures arm.
Neuralink announced that it has received the U.S. Food and Drug Administration's (FDA) "breakthrough" tag to restore communication for those with severe speech impairment.
